Publications by authors named "Stefan Niewiarowski"

Soluble plasma tissue factor (TF) circulates in picomolar concentrations in healthy individuals and increases in a wide spectrum of diseases. This study tests the hypothesis that both truncated TF (rsTF) or soluble plasmaTF (pTF) in low concentration combine with monocytes or platelets to convert factorVII (fVII) to fVIIa. Both rsTF (33 kDa) and pTF (47 kDa), obtained from pericardial wounds of patients having cardiac surgery using cardiopulmonary bypass (CPB), were studied in association with blood cells and TF-bearing microparticles.

View Article and Find Full Text PDF

The platelet-specific chemokine platelet factor 4 (PF4) is released in large amounts at sites of vascular injury. PF4 binds to heparin with high affinity, but its in vivo biologic role has not been defined. We studied the role of PF4 in thrombosis using heterozygote and homozygote PF4 knock-out mice (mPF4(+/-) and mPF4(-/-), respectively) and transgenic mice overexpressing human PF4 (hPF4(+)).

View Article and Find Full Text PDF

The effects of jarastatin (JT), a monomeric RGD-disintegrin, were compared with those of the heterodimeric MLD-disintegrin, EC3, on human neutrophil activation and functions. Both disintegrins inhibited neutrophil chemotaxis induced by fMet-Leu-Phe and were also potent chemotactic agents. These effects were accompanied by an increase in actin polymerization, and both were inhibited by genistein, a tyrosine kinase inhibitor.

View Article and Find Full Text PDF

Two highly homologous dimeric disintegrins, CC5 and CC8, have been isolated from the venom of the North African sand viper Cerastes cerastes. CC5 is a homodimer containing an RGD motif in its subunits. CC8 is a heterodimer.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Stefan Niewiarowski"

  • Stefan Niewiarowski's research primarily focuses on the role of tissue factors and disintegrins in the activation of blood coagulation and platelet response, exploring how these elements affect thrombosis and immune responses in humans.
  • His studies have demonstrated that both truncated and soluble tissue factors can activate factor VII when bound to monocytes, highlighting significant implications for understanding thrombotic conditions in diseases.
  • Additionally, he has investigated the effects of platelet factor 4 and disintegrins like jarastatin and EC3 on neutrophil function and integrin signaling, suggesting potential therapeutic targets for modulating immune and inflammatory responses.